COMMUNIQUÉS West-GlobeNewswire

Enzymatica AB: Bulletin from annual general meeting 2018 in Enzymatica AB (publ)
26/04/2018
Press release 26 April, 2018 Bulletin from annual general meeting 2018 in Enzymatica AB (publ) Enzymatica held its annual general meeting today 26 April 2018 in Lund. The meeting resolved upon the following: [...]
Kmart Pharmacy Joins Alzheimer’s Foundation of America to Raise Awareness and Offer Free Memory Screenings Nationwide this May
26/04/2018
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- The Alzheimer’s Foundation of America (AFA) and Kmart Pharmacy are continuing their strong collaboration in 2018, as Kmart will conduct free memory screenings at Kmart [...]
Loop Industries Appoints Nelson Switzer as Chief Growth Officer
26/04/2018
MONTREAL, April 26, 2018 (GLOBE NEWSWIRE) -- Loop™ Industries, Inc. (NASDAQ: LOOP ) today announced that it has appointed Nelson Switzer as Chief Growth Officer to lead the commercialization of Loop’s disruptive [...]
Tauriga Biz Dev. Corp. Enters into Reseller Agreement with Blink Charging Company; Agreement Presents the Company with Potential Long-Term Recurring Revenue Opportunity
26/04/2018
NEW YORK, NY, April 26, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
Aquinox to Present at 2018 Bloom Burton & Co. Healthcare Conference
26/04/2018
VANCOUVER, British Columbia, April 26, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
MS Society takes to Parliament Hill urging Members to act now to improve #LifeWithMS
26/04/2018
Secure income and employment, improved access, and investment in health research among priorities TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- From April 30 to May 2, 2018 representatives from the Multiple Sclerosis [...]
La Société de la SP se rend au Parlement pour inciter les députés à agir maintenant afin d’aider les gens à mieux #vivreaveclaSP
26/04/2018
Soutien de l’emploi, sécurité du revenu, accessibilité accrue et financement de la recherche en santé figurent parmi les priorités mises de l’avant par l’organisme TORONTO, 26 avr. 2018 (GLOBE NEWSWIRE) -- Du 30 avril [...]
Utah Medical Products, Inc. Reports Financial Performance for First Quarter 2018
26/04/2018
SALT LAKE CITY, April 26, 2018 (GLOBE NEWSWIRE) -- In the first calendar quarter (1Q) of 2018, Utah Medical Products, Inc. (Nasdaq: UTMD ) attained results consistent with achieving its financial goals for year 2018. [...]
Alphatec to Report First Quarter 2018 Financial Results on May 10, 2018
26/04/2018
CARLSBAD, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“Alphatec” or the “Company”) (Nasdaq: ATEC ), a provider of innovative spine surgery solutions with a mission to improve patient lives [...]
Knalysis Technologies is a KIRA Award Finalist!
26/04/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, April 26, 2018 (GLOBE NEWSWIRE) -- Knalysis Technologies (“Knalysis”), a subsidiary of Canada House Wellness Group Inc. (CSE: [...]
BioCorRx CEO Brady Granier and Actor Jeremy Miller Appear on Varney & Co. on Fox Business to Discuss the Company's Sustained Release Naltrexone Implant for Alcohol Use Disorder
26/04/2018
ANAHEIM, CA, April 26, 2018 (GLOBE NEWSWIRE) -- BioCorRx Inc. (OTCQB: BICX) (the "Company") , a developer and provider of advanced solutions in the treatment of alcohol and opioid addictions, today announced that Brady [...]
Minerva Neurosciences to Report First Quarter 2018 Financial Results and Business Updates on May 3, 2018
26/04/2018
Management to host conference call WALTHAM, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV ), a clinical-stage biopharmaceutical company focused on the development of therapies to [...]
Yield10 Addresses Application of Metabolic Engineering to Increase Crop Yield in Paper Published in Plant Science
26/04/2018
Chief Science Officer Kristi Snell also confirmed as a keynote speaker at upcoming plant meeting WOBURN, Mass., April 26, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN ), a Company developing new [...]
Emisphere Amends License Agreement with Novo Nordisk
26/04/2018
Emisphere to Receive $7 Million Payment ROSELAND, N.J., April 26, 2018 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (OTCBB: EMIS ) today announced that it has amended its existing 2015 Development and License [...]
Progenics Pharmaceuticals Sets First Quarter 2018 Financial Results Call for May 9
26/04/2018
NEW YORK, April 26, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, announced [...]
Corvus Pharmaceuticals Announces Initiation of Phase 1/1b Clinical Trial of Investigational Anti-CD73 Antibody, CPI-006, in Patients with Advanced Cancer
26/04/2018
Three-arm Trial Will Evaluate CPI-006 as Monotherapy, in Combination with CPI-444 Adenosine Antagonist and in Combination with Pembrolizumab BURLINGAME, Calif., April 26, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals [...]
Agritek Holdings, Inc. Announces Purchase And Transfer Of Tier One Recreational License For Colorado On Behalf Of Approved Partner Licensee With Existing Cannabis Operations
26/04/2018
Company Expands Operations In Colorado On Heel Of New Deal With President Trump And Senator Cory Gardner Clearing Way For Colorado Medical And Recreational Cannabis LOS ANGELES, CA, April 26, 2018 (GLOBE NEWSWIRE) -- [...]
William Hartman, CEO of Premier Biomedical, Returns to Uptick Newswire’s “Stock Day” Podcast
26/04/2018
PHOENIX, April 26, 2018 (GLOBE NEWSWIRE) -- William Hartman, CEO of Premier Biomedical Inc. (OTCBB: BIEI ) ("the Company") joined Everett Jolly on Uptick Newswire’s “Stock Day” podcast to discuss recent company [...]
Alder BioPharmaceuticals® Appoints Jeremy Green to its Board of Directors
26/04/2018
BOTHELL, Wash., April 26, 2018 (GLOBE NEWSWIRE) -- Alder Biopharmaceuticals, Inc. (NASDAQ: ALDR ) (“Alder” or the “Company”), a biopharmaceutical company focused on developing novel therapeutic antibodies for the [...]

Pages